メディカルアフェアーズの評判 (欧州)：アトピー性皮膚炎

本レポートでは、アトピー性皮膚炎治療薬を支援するメディカルアフェアーズチームの競争力および評判について、欧州各国の皮膚科医のフィードバックに基づいて分析したものです。医師がメディカルアフェアーズチームとどのように関わっているか、どのサービスが最も重視されているか、製品別の満足度、好まれるコミュニケーション手段や頻度について、詳細なインサイトを提供しています。さらに、メディカルアフェアーズチームが今後の治療環境において、より医師のニーズに応えるために強化すべき領域も明らかにしています。

主な質問

• 1.医師はどの程度の頻度でメディカルアフェアーズチームと接触しており、その頻度は増加しているか減少しているか？
• 2.医師は現在、メディカルアフェアーズチームが提供するサービスをどのように活用しているか？
• 3.医師にとってメディカルアフェアーズの支援で最も重要なのは何か？また、その支援に対する満足度はどの程度か？
• 4.医師がメディカルアフェアーズチームとのやり取りに好む手段は何か？また、望ましい接触頻度はどの程度か？
• 5.メディカルアフェアーズチームは、医師のニーズにどの程度応えられているか？
• 6.特定のブランドにおいて、メディカルアフェアーズチームは期待を下回っているか、それとも上回っているか？
• 7.将来的に医師のニーズによりよく応えるために、メディカルアフェアーズのサービスはどのように改善できるか？
• 8.競合他社のメディカルアフェアーズチームの強みと弱みはそれぞれどこにあるか？

主要ブランド

This report examines the competitive performance and reputation of Medical Affairs teams supporting therapies for atopic dermatitis, based on feedback from dermatologists across Europe. It provides detailed insights into how physicians currently engage with Medical Affairs teams, the services they value most, satisfaction levels by product, and preferred channels and frequency of interaction. The findings also highlight areas where Medical Affairs teams can strengthen their support to better meet physician needs in an evolving treatment landscape.

Key Questions Answered:

• 1. How frequently do physicians interact with Medical Affairs teams, and is the frequency of this interaction increasing or decreasing?
• 2. In what ways do physicians currently use the services provided by Medical Affairs teams?
• 3. What aspects of Medical Affairs support are most important to physicians and how satisfied are they with the support provided?
• 4. What are the preferred mediums for interactions between physicians and Medical Affairs teams and what is the preferred frequency of these interactions?
• 5. How successful are Medical Affairs teams at meeting physician needs?
• 6. Are Medical Affairs teams falling short or exceeding goals with any particular brands?
• 7. How can Medical Affairs services be improved to better meet the needs of physicians in the future?
• 8. In what areas are your competitors' Medical Affairs teams weakest and strongest?

Key Brands:

Methodology:

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.